OS070. Shared genetic risk factors for preeclampsia and cardiovascular disease

M Løset; M P Johnson; C Pennell; R-C Huang; T Mori; L Beilin; P Melton; L T Roten; A-C Iversen; R Austgulen; C East; J Blangero; S P Brennecke; E K Moses

doi:10.1016/j.preghy.2012.04.071

OS070. Shared genetic risk factors for preeclampsia and cardiovascular disease

Pregnancy Hypertens. 2012 Jul;2(3):214-5. doi: 10.1016/j.preghy.2012.04.071. Epub 2012 Jun 13.

Authors

M Løset¹, M P Johnson², C Pennell³, R-C Huang³, T Mori³, L Beilin³, P Melton², L T Roten¹, A-C Iversen¹, R Austgulen¹, C East⁴, J Blangero², S P Brennecke⁴, E K Moses³

Affiliations

¹ Norwegian University of Science and Technology, Trondheim, Norway.
² Texas Biomedical Research Institute, San Antonio, United States.
³ The University of Western Australia, Perth, Australia.
⁴ The Royal Women's Hospital, Melbourne, Australia.

PMID: 26105283
DOI: 10.1016/j.preghy.2012.04.071

Abstract

Introduction: There is compelling evidence to support the hypothesis that a maternal constitutional predisposition to cardiovascular disease (CVD) is a key component in development of preeclampsia. In particular, CVD and preeclampsia share pathological features such as endothelial dysfunction and inflammation, and have several metabolic abnormalities in common. In support of this hypothesis, our recent genetic dissection of the Australian preeclampsia susceptibility locus on chromosome 2q22 revealed shared novel genetic risk factors for preeclampsia and CVD-related traits.

Objectives: To replicate association between our recently reported 2q22 preeclampsia risk variants and CVD-related traits in an independent Australian population based cohort.

Methods: Four independent SNPs from four genes, rs35821928 (LRP1B), rs17783344 (GCA), rs115015150 (RND3) and rs2322659 (LCT), were recently found to be significantly associated with preeclampsia susceptibility and CVD-related traits. These SNPs were genotyped in a large independent Australian cohort rich in quantitative CVD risk traits; The Western Australian Pregnancy Cohort (Raine) Study. This cohort comprises of blood samples from 1246 mothers and 1461 adolescents and clinical measures such as, but not limited to, anthropometric measures of adiposity and lipid-related measures. Genetic association analyses of these four potential preeclampsia susceptibility SNPs against the CVD-related risk traits were performed using the software package R. All statistical analyses assumed an additive model of gene action.

Results: Several significant associations (p<0.05) for all four SNPs with a variety of CVD-related risk traits were detected, both for the mothers and the adolescents. The LRP1B SNP was associated with HDL/cholesterol ratio, LDL cholesterol, triglycerides, skinfold measures and weight. The GCA SNP was associated with total cholesterol, HDL cholesterol, serum insulin, hemoglobin, blood glucose, BMI and skinfold measures. The RND3 SNP was associated with triglycerides and waist-hip ratio. The LCT SNP was associated with hemoglobin, blood glucose and abdominal skinfold.

Conclusion: We have recently identified genetic variants within the LRP1B, GCA, RND3 and LCT genes to be significantly associated with preeclampsia susceptibility and CVD-related risk traits. We have now demonstrated thatthese specific genetic variants are associated with CVD-related risk traits in an independent population. Our collective findings provide substantial empirical data to support the hypothesis that genetic risk factors for preeclampsia and CVD are, at least in part, shared.